Corbus Pharmaceuticals Holdings, Inc. (CRBP) financial statements (2021 and earlier)

Company profile

Business Address 500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8532426315126
Cash and cash equivalents8532426315126
Restricted cash and investments0  00  
Receivables    1  
Prepaid expense  2 100
Other undisclosed current assets66 30  
Total current assets:9238446617137
Noncurrent Assets
Operating lease, right-of-use asset56
Property, plant and equipment4531000
Restricted cash and investments1   000
Other noncurrent assets0000   
Total noncurrent assets:101131000
TOTAL ASSETS:10249476718137
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2934168721
Accounts payable71163310
Accrued liabilities2222105310
Debt1100000
Deferred rent credit  0
Derivative instruments and hedges, liabilities1      
Deferred revenue and credits 22 
Contract with customer, liability1
Other undisclosed current liabilities1      
Total current liabilities:3235188941
Noncurrent Liabilities
Long-term debt and lease obligation258     
Long-term debt, excluding current maturities18      
Operating lease, liability78
Liabilities, other than long-term debt  1100 
Deferred revenue and credits100 
Deferred rent credit  1
Other liabilities   00  
Other undisclosed noncurrent liabilities(7)      
Total noncurrent liabilities:2581100 
Total liabilities:5743199941
Stockholders' equity
Stockholders' equity attributable to parent, including:4562858996
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable    (0)  
Additional paid in capital349199149123422210
Accumulated deficit(304)(193)(121)(66)(33)(13)(4)
Other undisclosed stockholders' equity attributable to parent    0  
Total stockholders' equity:4562858996
TOTAL LIABILITIES AND EQUITY:10249476718137

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Gross profit:4365221 
Operating expenses(127)(113)(62)(35)(22)(10)(3)
Operating loss:(123)(77)(57)(33)(20)(9)(3)
Nonoperating income (expense)12610(0)00
Investment income, nonoperating 1   00
Foreign currency transaction gain (loss), before tax(0)(0)0(0)(0)00
Other nonoperating income 5     
Interest and debt expense(1)  (0)(0)(0)0
Net loss:(112)(71)(56)(32)(20)(9)(2)
Other undisclosed net income (loss) attributable to parent1  000(0)
Net loss available to common stockholders, diluted:(111)(71)(56)(32)(20)(9)(3)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(112)(71)(56)(32)(20)(9)(2)
Comprehensive loss, net of tax, attributable to parent:(112)(71)(56)(32)(20)(9)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: